BridGene Biosciences and Galapagos NV Join Forces in Landmark Collaboration for Oncology Drug Discovery
BridGene Biosciences, Inc., a trailblazer in small molecule drug discovery for challenging targets, has announced a strategic collaboration and licensing agreement... Read more.
AbelZeta Pharma, Inc. Establishes Scientific Advisory Board to Propel Advancements in Inflammatory and Immunological Diseases
AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company specializing in the discovery and development of innovative cell-based therapeutic products,... Read more.
Hi-Tech Pharmaceuticals Expands Production Capabilities to Revolutionize Dietary Supplements and OTC Drugs
Hi-Tech Pharmaceuticals, Inc., a leading global healthcare supplier, has announced a significant expansion in its manufacturing capabilities for dietary supplements... Read more.
Novartis Secures Groundbreaking $100 Million Deal with Voyager for Cutting-Edge Gene Therapy Partnership
On January 2, Voyager Therapeutics announced a significant licensing deal with Swiss-based drugmaker Novartis, wherein Novartis would make an upfront payment of... Read more.
Glenmark Makes History: Unveils India’s First Biosimilar of Liraglutide, a Game-Changer in Diabetes Treatment
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide,... Read more.
MediLink’s Global Pact with Roche Unveils Revolutionary Oncology Breakthrough
MediLink Therapeutics has recently unveiled a groundbreaking collaboration and license agreement with Roche, a leading pharmaceutical company, for the development... Read more.
US FDA Approvals Bounce Back In 2023, Sparking Hopes of a Biotech Recovery
The surge in U.S. Food and Drug Administration (FDA) approvals in 2023 has ignited optimism within the biotech industry, signaling a potential recovery. The approval... Read more.
Top 10 Active Pharmaceutical Ingredients (APIs) and Leading Companies In The Sector
Active Pharmaceutical Ingredients (APIs) serve as the essential bioactive components in pharmaceutical drugs, whether synthesized chemically, produced through biotechnological... Read more.
Ascentage Pharma Takes Center Stage: CEO Dr. Dajun Yang to Unveil Innovations at 42nd J.P. Morgan Healthcare Conference
Ascentage Pharma, a global biopharmaceutical company specializing in novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, has announced... Read more.
Dollar Landscape of Biological Drug API Manufacturing Services – A Decade of Growth and Collaboration (2023-2033)
The Biological Drug API Manufacturing Services Market Report for 2023-2033, presented by Research and Markets, underscores key developments in the sector. It anticipates... Read more.